MCID: BRS056
MIFTS: 47

Breast Metaplastic Carcinoma

Categories: Cancer diseases, Rare diseases, Reproductive diseases

Aliases & Classifications for Breast Metaplastic Carcinoma

MalaCards integrated aliases for Breast Metaplastic Carcinoma:

Name: Breast Metaplastic Carcinoma 12 15
Metaplastic Carcinoma of the Breast 12 52 58
Metaplastic Breast Carcinoma 17 71
Metaplastic Carcinoma of Breast 12
Metaplastic Breast Cancer 52

Classifications:

Orphanet: 58  
Rare gynaecological and obstetric diseases


External Ids:

Disease Ontology 12 DOID:4680
NCIt 49 C5164
SNOMED-CT 67 763479005
UMLS via Orphanet 72 C1334708
Orphanet 58 ORPHA213531
UMLS 71 C1334708

Summaries for Breast Metaplastic Carcinoma

NIH Rare Diseases : 52 Metaplastic carcinoma of the breast is a rare form of breast cancer . The tumor cells differ in type from that of the typical ductal or lobular breast cancers . The cells look like skin cells or cells that make bone. Some women experience no early signs or symptoms, while others experience general symptoms of breast cancers, such as new breast lumps . Treatment of metaplastic carcinoma of the breast is similar to that of invasive ductal cancer .

MalaCards based summary : Breast Metaplastic Carcinoma, also known as metaplastic carcinoma of the breast, is related to breast squamous cell carcinoma and benign breast phyllodes tumor, and has symptoms including pain An important gene associated with Breast Metaplastic Carcinoma is ERBB2 (Erb-B2 Receptor Tyrosine Kinase 2), and among its related pathways/superpathways are Gastric cancer and Relaxin signaling pathway. The drugs Ipilimumab and nivolumab have been mentioned in the context of this disorder. Affiliated tissues include breast, bone and skin, and related phenotypes are Decreased viability and Decreased viability

Disease Ontology : 12 A breast carcinoma that represents a mixed group of malignant neoplasms characterized by the histologic presence of two or more cellular types.

Related Diseases for Breast Metaplastic Carcinoma

Diseases related to Breast Metaplastic Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 303, show less)
# Related Disease Score Top Affiliating Genes
1 breast squamous cell carcinoma 31.7 KRT5 ERBB2 BDP1 BCYRN1
2 benign breast phyllodes tumor 30.4 PGR MME
3 subareolar duct papillomatosis 30.3 MME KRT5
4 sarcomatoid squamous cell skin carcinoma 30.3 MME KRT5
5 pleomorphic adenoma 30.2 MAML2 KRT14 ERBB2
6 carcinosarcoma 30.1 PGR MME ERBB2 EGFR
7 adenosquamous carcinoma 30.0 PGR MAML2 KRT5 EGFR
8 epithelial-myoepithelial carcinoma 29.9 MAML2 KRT14
9 mulchandani-bhoj-conlin syndrome 29.9 PGR MME ESR1 ERBB2
10 breast adenocarcinoma 29.9 PGR ESR1 ERBB2 EGFR
11 spindle cell carcinoma 29.8 PGR KRT5 KRT14 ESR1
12 inflammatory breast carcinoma 29.7 PGR ESR1 ERBB2 EGFR
13 female breast cancer 29.6 PGR ESR1 ERBB2 EGFR
14 papilloma 29.6 KRT5 KRT14 ESR1 EGFR
15 squamous cell carcinoma 29.5 KRT14 ERBB2 EGFR BCYRN1
16 intraductal papilloma 29.5 PGR KRT5 KRT14 ESR1 ERBB2
17 lipid-rich carcinoma 29.5 PGR KRT5 KRT14 ESR1 ERBB2
18 myeloma, multiple 29.3 MME ESR1 ERBB2 EGFR
19 adenoid cystic carcinoma 29.3 PGR KRT5 KRT14 ERBB2 EGFR
20 breast fibroadenoma 29.2 PGR MME KRT14 ESR1 ERBB2
21 tubular adenocarcinoma 29.1 PGR MME ESR1 ERBB2 EGFR
22 in situ carcinoma 28.9 PGR KRT5 KRT14 ESR1 ERBB2 EGFR
23 ductal carcinoma in situ 28.3 PGR MME KRT5 KRT14 ESR1 ERBB2
24 breast mucoepidermoid carcinoma 11.5
25 adenosquamous breast carcinoma 11.5
26 mixed epithelial/mesenchymal metaplastic breast carcinoma 11.5
27 scirrhous adenocarcinoma 10.4 PGR ERBB2
28 breast cystic hypersecretory carcinoma 10.4 KRT5 ERBB2
29 apocrine adenosis of breast 10.4 PGR ERBB2
30 vulva basal cell carcinoma 10.4 KRT5 ERBB2
31 bartholin's gland adenoid cystic carcinoma 10.4 PGR ESR1
32 chronic tympanitis 10.4 PGR ESR1
33 bartholin's gland adenoma 10.4 PGR ESR1
34 granulomatous endometritis 10.4 PGR ESR1
35 bartholin's gland benign neoplasm 10.4 PGR ESR1
36 vestibular gland benign neoplasm 10.4 PGR ESR1
37 breast adenomyoepithelioma 10.4 KRT5 KRT14
38 pregnancy adenoma 10.4 PGR KRT5
39 breast adenoid cystic carcinoma 10.4 PGR ERBB2
40 basaloid lung carcinoma 10.4 PGR KRT5
41 vaginal glandular tumor 10.4 PGR ESR1
42 external ear carcinoma 10.4 PGR KRT5
43 lung leiomyoma 10.4 PGR ESR1
44 vulvar syringoma 10.4 PGR ESR1
45 trigonitis 10.4 PGR ESR1
46 laryngeal mucoepidermoid carcinoma 10.4 KRT14 ERBB2
47 cervical clear cell adenocarcinoma 10.4 PGR ESR1
48 linitis plastica 10.4 PGR ERBB2
49 triple-receptor negative breast cancer 10.4 PGR ERBB2
50 adult type testicular granulosa cell tumor 10.4 PGR ESR1
51 ovarian seromucinous carcinoma 10.4 PGR ESR1
52 liver leiomyoma 10.4 PGR ESR1
53 mammographic density 10.4 PGR ESR1
54 rare tumor 10.4
55 bizarre leiomyoma 10.4 PGR ESR1
56 ceruminous adenocarcinoma 10.3 KRT5 KRT14
57 breast myoepithelial neoplasm 10.3 KRT5 KRT14
58 squamous cell bile duct carcinoma 10.3 KRT5 KRT14
59 polyp of corpus uteri 10.3 PGR KRT14
60 epidermolysis bullosa simplex, autosomal recessive 1 10.3 KRT5 KRT14
61 parotid gland cancer 10.3 ERBB2 BCYRN1
62 odontoma 10.3 KRT5 KRT14
63 progesterone resistance 10.3 PGR ESR1
64 uterus leiomyosarcoma 10.3 PGR KRT5
65 large cell acanthoma 10.3 KRT5 KRT14
66 biphasic synovial sarcoma 10.3 PGR ESR1
67 malignant acrospiroma 10.3 MAML2 KRT5
68 juvenile nasopharyngeal angiofibroma 10.3 PGR ESR1
69 cutaneous mucoepidermoid carcinoma 10.3 MAML2 KRT5
70 epidermolysis bullosa simplex, localized 10.3 KRT5 KRT14
71 gender identity disorder 10.3 PGR ESR1
72 pleomorphic adenoma carcinoma 10.3 MAML2 ERBB2
73 cervical adenomyoma 10.3 PGR MME
74 fallopian tube endometriosis 10.3 PGR MME
75 cervical benign neoplasm 10.3 PGR MME
76 osteogenic sarcoma 10.3
77 necrotizing sialometaplasia 10.3 MAML2 KRT5
78 recurrent respiratory papillomatosis 10.3 ERBB2 EGFR
79 estrogen excess 10.3 PGR ESR1
80 bile duct mucoepidermoid carcinoma 10.3 MAML2 KRT5
81 chondrosarcoma 10.3
82 cervical serous adenocarcinoma 10.3 PGR MME
83 clear cell basal cell carcinoma 10.3 KRT5 KRT14
84 paget disease, extramammary 10.3 KRT5 ERBB2
85 rare malignant breast tumor 10.3
86 breast leiomyoma 10.2 PGR MME
87 endometrial serous adenocarcinoma 10.2 PGR ERBB2
88 benign peritoneal mesothelioma 10.2 KRT5 KRT14
89 adult cystic nephroma 10.2 PGR MME
90 nipple benign neoplasm 10.2 MME KRT5
91 nephroma 10.2 PGR MME
92 cystic basal cell carcinoma 10.2 KRT5 KRT14
93 breast myofibroblastoma 10.2 MME ESR1
94 eccrine porocarcinoma 10.2 MAML2 KRT5
95 lipid-rich breast carcinoma 10.2 PGR KRT5 ERBB2
96 reticulate acropigmentation of kitamura 10.2 KRT5 KRT14
97 cervical polyp 10.2 PGR MME
98 breast mucinous carcinoma 10.2 PGR KRT5 ERBB2
99 cervix erosion 10.2 MME KRT5
100 papillary carcinoma 10.2 PGR ESR1 ERBB2
101 malignant spiradenoma 10.2 PGR KRT5 ERBB2
102 glassy cell carcinoma of the cervix 10.2 PGR ESR1 ERBB2
103 epidermolysis bullosa simplex, generalized 10.2 KRT5 KRT14
104 amelogenesis imperfecta 10.2 PGR ESR1 ERBB2
105 comedo carcinoma 10.2 PGR ESR1 ERBB2
106 pancreatic mucinous cystadenoma 10.2 PGR MME
107 borst-jadassohn intraepidermal carcinoma 10.2 KRT5 KRT14
108 submandibular gland cancer 10.2 ERBB2 EGFR
109 ovarian endometrioid stromal sarcoma 10.2 PGR MME
110 bladder lateral wall cancer 10.2 MME ERBB2
111 endobronchial lipoma 10.2 MAML2 KRT5
112 progesterone-receptor positive breast cancer 10.2 PGR ESR1 ERBB2
113 papillary squamous carcinoma 10.2 KRT5 EGFR
114 breast cancer 10.2
115 female reproductive endometrioid cancer 10.2 PGR ESR1 ERBB2
116 balloon cell malignant melanoma 10.2 MME KRT5
117 endocervical carcinoma 10.2 PGR ESR1 ERBB2
118 nephrogenic adenoma of the urethra 10.2 MME KRT5
119 biliary tract cancer 10.2 ERBB2 EGFR
120 vaginal discharge 10.2 PGR ESR1
121 endocervical adenocarcinoma 10.2 PGR ESR1 ERBB2
122 cystadenofibroma 10.2 MME KRT5
123 fallopian tube endometrioid adenocarcinoma 10.2 MME ERBB2
124 esophageal basaloid squamous cell carcinoma 10.2 KRT14 EGFR
125 basaloid squamous cell carcinoma 10.2 KRT14 EGFR
126 wolffian duct adenocarcinoma 10.2 MME ESR1
127 bilateral breast cancer 10.2 PGR ESR1 ERBB2
128 fallopian tube carcinoma 10.2 PGR ESR1 ERBB2
129 teeth hard tissue disease 10.2 PGR ESR1 ERBB2
130 gynecomastia 10.2 PGR ESR1 ERBB2
131 paronychia 10.2 ERBB2 EGFR
132 nasal cavity olfactory neuroblastoma 10.2 MME KRT5
133 cervical adenoma malignum 10.2 PGR MME
134 epididymis adenocarcinoma 10.2 MME KRT5
135 epididymis cancer 10.2 MME KRT5
136 esophageal adenosquamous carcinoma 10.2 KRT5 KRT14 ERBB2
137 sebaceous adenocarcinoma 10.2 KRT5 KRT14 ERBB2
138 breast myoepithelial carcinoma 10.2 PGR KRT5 KRT14
139 central epithelioid sarcoma 10.1 MME KRT5
140 lung non-squamous non-small cell carcinoma 10.1 ERBB2 EGFR
141 vulvar proximal-type epithelioid sarcoma 10.1 MME KRT5
142 sarcoma 10.1
143 spindle cell sarcoma 10.1
144 pseudosarcomatous fibromatosis 10.1
145 fasciitis 10.1
146 gastroesophageal junction adenocarcinoma 10.1 ERBB2 EGFR
147 fibromatosis 10.1
148 periampullary adenocarcinoma 10.1 ERBB2 EGFR
149 cervical adenosquamous carcinoma 10.1 MAML2 EGFR
150 primary peritoneal carcinoma 10.1 PGR ERBB2 EGFR
151 epidermolysis bullosa simplex with mottled pigmentation 10.1 KRT5 KRT14
152 vulvar disease 10.1 PGR ERBB2 EGFR
153 placental site trophoblastic tumor 10.0 ERBB2 EGFR
154 cutaneous adenocystic carcinoma 10.0 PGR MME KRT5
155 endometriosis of ovary 10.0 PGR ESR1
156 eccrine acrospiroma 10.0 MAML2 KRT5 KRT14
157 eccrine sweat gland neoplasm 10.0 MAML2 KRT5 KRT14
158 uterine corpus adenosarcoma 10.0 PGR MME ESR1
159 intravenous leiomyomatosis 10.0 PGR MME ESR1
160 leiomyoma 10.0 PGR MME ESR1
161 uterine body mixed cancer 10.0 ESR1 ERBB2 EGFR
162 vulvar leiomyoma 10.0 PGR MME ESR1
163 vaginal endometrial stromal sarcoma 10.0 PGR MME ESR1
164 endometrial stromal sarcoma 10.0 PGR MME ESR1
165 adenomyoma 10.0 PGR MME ESR1
166 vagina sarcoma 10.0 PGR MME ESR1
167 vaginal cancer 10.0 PGR MME ESR1
168 large cell carcinoma 10.0 KRT5 ERBB2 EGFR
169 neurofibromatosis, type ii 10.0 PGR ERBB2 EGFR
170 smooth muscle tumor 10.0 PGR MME ESR1
171 endometrial stromal tumor 10.0 PGR MME ESR1
172 prostatic hypertrophy 10.0 PGR ESR1 EGFR
173 peritoneal mesothelioma 10.0 PGR ESR1 EGFR
174 uterine benign neoplasm 10.0 PGR MME ESR1
175 reproductive organ benign neoplasm 10.0 PGR MME ESR1
176 adenomyosis 10.0 PGR MME ESR1
177 angiomyolipoma 10.0 PGR MME ESR1
178 peritoneum cancer 10.0 KRT5 EGFR
179 pleomorphic carcinoma 10.0 PGR KRT14 EGFR
180 micronodular basal cell carcinoma 10.0 MME KRT5 KRT14
181 hair disease 10.0 KRT14 ERBB2 EGFR
182 breast papillary carcinoma 10.0 PGR KRT5 ESR1 ERBB2
183 lymphangioleiomyomatosis 10.0 PGR ESR1 EGFR
184 cribriform carcinoma 10.0 PGR KRT5 ESR1 ERBB2
185 lobular neoplasia 10.0 PGR KRT5 ESR1 ERBB2
186 sweat gland cancer 10.0 PGR KRT5 ESR1 ERBB2
187 li-fraumeni syndrome 10.0 ESR1 ERBB2 EGFR
188 skin papilloma 10.0 KRT14 EGFR
189 ovarian cancer 10.0
190 retinoblastoma 10.0
191 angiosarcoma 10.0
192 polycystic kidney disease 10.0
193 breast cyst 10.0
194 squamous cell papilloma 10.0
195 malignant fibrous histiocytoma 10.0
196 myoepithelioma 10.0
197 transitional cell carcinoma 10.0
198 adenocarcinoma 10.0
199 rhabdomyosarcoma 10.0
200 fibrosarcoma 10.0
201 hyperglycemia 10.0
202 fibrous histiocytoma 10.0
203 familial retinoblastoma 10.0
204 renal pelvis carcinoma 10.0
205 adenoma 10.0
206 neuroblastoma 10.0
207 end stage renal disease 10.0
208 keloid disorder 10.0
209 47,xyy 10.0
210 pseudoangiomatous stromal hyperplasia 10.0
211 colorectal cancer 10.0
212 congenital heart defects, hamartomas of tongue, and polysyndactyly 10.0
213 sarcoma, synovial 10.0
214 ewing sarcoma 10.0
215 lung cancer susceptibility 3 10.0
216 inflammatory myofibroblastic tumor 10.0
217 leiomyosarcoma 10.0
218 malignant mesenchymoma 10.0
219 b-cell lymphoma 10.0
220 sickle cell disease 10.0
221 chromosomal triplication 10.0
222 specific language disorder 10.0
223 mesenchymal cell neoplasm 10.0
224 neurofibromatosis 10.0
225 rapidly involuting congenital hemangioma 10.0
226 skin squamous cell carcinoma 10.0 KRT5 KRT14 EGFR
227 vesiculobullous skin disease 10.0 KRT5 KRT14
228 myositis 9.9
229 neurofibromatosis, type i 9.9
230 ptosis 9.9
231 breast abscess 9.9
232 skin benign neoplasm 9.9
233 liposarcoma 9.9
234 myoepithelial carcinoma 9.9
235 malignant syringoma 9.9
236 breast liposarcoma 9.9
237 pleomorphic liposarcoma 9.9
238 myositis ossificans 9.9
239 pulmonary embolism 9.9
240 perivascular epithelioid cell tumor 9.9 PGR MME
241 oncocytic breast carcinoma 9.9 PGR KRT14 ESR1 ERBB2
242 breast disease 9.9 PGR KRT5 ESR1 ERBB2
243 clear cell hidradenoma 9.9 MME MAML2 KRT5
244 hidradenoma 9.9 MME MAML2 KRT5
245 keratinizing squamous cell carcinoma 9.9 MAML2 KRT5 EGFR
246 breast sarcoma 9.8 PGR MME KRT5 ERBB2
247 leukocyte disease 9.8 MME ERBB2 EGFR
248 bone cancer 9.8 PGR ESR1 EGFR
249 breast scirrhous carcinoma 9.8 PGR ESR1 ERBB2 EGFR
250 progesterone-receptor negative breast cancer 9.8 PGR ESR1 ERBB2 EGFR
251 microglandular adenosis 9.8 PGR ESR1 ERBB2 EGFR
252 hypertrophy of breast 9.8 PGR ESR1 ERBB2 EGFR
253 adenosarcoma 9.8 PGR MME ESR1 ERBB2
254 short syndrome 9.8 PGR ESR1 ERBB2 EGFR
255 uterine corpus cancer 9.8 PGR ESR1 ERBB2 EGFR
256 amelogenesis imperfecta, type ig 9.8 PGR ESR1 ERBB2 EGFR
257 glioma susceptibility 1 9.8 ERBB2 EGFR BCYRN1
258 estrogen-receptor negative breast cancer 9.8 PGR ESR1 ERBB2 EGFR
259 mucinous adenocarcinoma 9.8 PGR ESR1 ERBB2 EGFR
260 sporadic breast cancer 9.8 PGR ESR1 ERBB2 EGFR
261 endometrial adenocarcinoma 9.8 PGR ESR1 ERBB2 EGFR
262 estrogen-receptor positive breast cancer 9.8 PGR ESR1 ERBB2 EGFR
263 cervical adenocarcinoma 9.8 PGR ESR1 ERBB2 EGFR
264 ovary adenocarcinoma 9.8 PGR ESR1 ERBB2 EGFR
265 ovary epithelial cancer 9.8 PGR ESR1 ERBB2 EGFR
266 malignant ovarian surface epithelial-stromal neoplasm 9.8 PGR ESR1 ERBB2 EGFR
267 ovarian serous cystadenocarcinoma 9.8 PGR ESR1 ERBB2 EGFR
268 urethral benign neoplasm 9.8 PGR MME KRT5 ESR1
269 gastroesophageal adenocarcinoma 9.8 ERBB2 EGFR
270 meningioma, familial 9.8 PGR ESR1 ERBB2 EGFR
271 wilms tumor 1 9.8 PGR ESR1 ERBB2 EGFR
272 ovarian disease 9.8 PGR ESR1 ERBB2 EGFR
273 eccrine papillary adenocarcinoma 9.8 PGR MME KRT5 KRT14
274 endometrial disease 9.8 PGR ESR1
275 renal cell carcinoma, papillary, 1 9.8 MME ERBB2 EGFR
276 benign breast adenomyoepithelioma 9.7 KRT5 KRT14 ESR1 EGFR
277 salivary gland disease 9.7 MAML2 KRT5 ERBB2 EGFR
278 salivary gland carcinoma 9.7 MAML2 KRT5 ERBB2 EGFR
279 apocrine sweat gland neoplasm 9.7 PGR KRT5 KRT14 ESR1 ERBB2
280 cholangiocarcinoma 9.7 MME ERBB2 EGFR
281 myoma 9.6 PGR MME ESR1 EGFR
282 basal cell carcinoma 9.6 MME KRT5 KRT14 EGFR
283 breast osteosarcoma 9.6 PGR MME KRT5 ESR1 ERBB2
284 apocrine adenocarcinoma 9.6 PGR KRT5 ESR1 ERBB2 EGFR
285 mammary paget's disease 9.5 PGR KRT14 ESR1 ERBB2 EGFR
286 suppression of tumorigenicity 12 9.5 KRT5 KRT14 ESR1 ERBB2 EGFR
287 mucoepidermoid carcinoma 9.4 MAML2 KRT5 KRT14 ERBB2 EGFR
288 uterine carcinosarcoma 9.4 PGR MME ESR1 ERBB2 EGFR
289 cervical cancer 9.4 KRT14 ESR1 ERBB2 EGFR BCYRN1
290 sweat gland disease 9.4 PGR MAML2 KRT5 KRT14 ESR1 ERBB2
291 intraductal breast benign neoplasm 9.3 PGR MME KRT5 KRT14 ESR1 ERBB2
292 luminal breast carcinoma a 9.3 PGR KRT5 KRT14 ESR1 ERBB2 EGFR
293 pre-malignant neoplasm 9.3 PGR KRT5 KRT14 ESR1 ERBB2 EGFR
294 breast carcinoma in situ 9.3 PGR KRT5 KRT14 ESR1 ERBB2 EGFR
295 breast ductal carcinoma 9.3 PGR KRT5 KRT14 ESR1 ERBB2 EGFR
296 sweat gland benign neoplasm 9.2 PGR MME MAML2 KRT5 KRT14 ERBB2
297 oropharynx cancer 9.2 PGR MAML2 KRT5 KRT14 ERBB2 EGFR
298 endometrial cancer 9.2 PGR MME ESR1 ERBB2 EGFR
299 breast malignant phyllodes tumor 9.2 PGR MME KRT5 ESR1 ERBB2 EGFR
300 mixed cell type cancer 9.2 PGR MME KRT5 ESR1 ERBB2 EGFR
301 tonsil cancer 9.0 PGR MAML2 KRT5 KRT14 ESR1 ERBB2
302 breast benign neoplasm 8.9 PGR MME KRT5 KRT14 ESR1 ERBB2
303 thoracic benign neoplasm 8.9 PGR MME KRT5 KRT14 ESR1 ERBB2

Graphical network of the top 20 diseases related to Breast Metaplastic Carcinoma:



Diseases related to Breast Metaplastic Carcinoma

Symptoms & Phenotypes for Breast Metaplastic Carcinoma

UMLS symptoms related to Breast Metaplastic Carcinoma:


pain

GenomeRNAi Phenotypes related to Breast Metaplastic Carcinoma according to GeneCards Suite gene sharing:

26 (showing 10, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00055-A-1 9.5 EGFR
2 Decreased viability GR00055-A-2 9.5 EGFR
3 Decreased viability GR00107-A-1 9.5 CLK3
4 Decreased viability GR00221-A-1 9.5 EGFR ESR1
5 Decreased viability GR00221-A-2 9.5 CLK3 ESR1
6 Decreased viability GR00221-A-3 9.5 ERBB2
7 Decreased viability GR00221-A-4 9.5 CLK3 EGFR ERBB2 ESR1
8 Decreased viability GR00301-A 9.5 CLK3
9 Decreased viability GR00386-A-1 9.5 ESR1
10 Decreased viability GR00402-S-2 9.5 ESR1

MGI Mouse Phenotypes related to Breast Metaplastic Carcinoma:

45 (showing 3, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 integument MP:0010771 9.7 EGFR ERBB2 ESR1 KRT14 KRT5 MME
2 limbs/digits/tail MP:0005371 9.35 EGFR ERBB2 ESR1 KRT5 PGR
3 neoplasm MP:0002006 9.02 EGFR ERBB2 ESR1 KRT14 PGR

Drugs & Therapeutics for Breast Metaplastic Carcinoma

Drugs for Breast Metaplastic Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 6, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ipilimumab Approved Phase 2 477202-00-9
2
nivolumab Approved Phase 2 946414-94-4
3 Immunoglobulins Phase 2
4 Antibodies Phase 2
5 Antibodies, Monoclonal Phase 2
6 Antineoplastic Agents, Immunological Phase 2

Interventional clinical trials:

(showing 1, show less)
# Name Status NCT ID Phase Drugs
1 DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors Recruiting NCT02834013 Phase 2

Search NIH Clinical Center for Breast Metaplastic Carcinoma

Genetic Tests for Breast Metaplastic Carcinoma

Anatomical Context for Breast Metaplastic Carcinoma

MalaCards organs/tissues related to Breast Metaplastic Carcinoma:

40
Breast, Bone, Skin, Lung, Lymph Node, Colon, T Cells

Publications for Breast Metaplastic Carcinoma

Articles related to Breast Metaplastic Carcinoma:

(showing 143, show less)
# Title Authors PMID Year
1
Metaplastic Carcinoma of the Breast: Analysis of 38 Cases from a Single Institute. 61
31769499 2020
2
Spindle cell metaplastic carcinoma of the breast. 61
31908098 2020
3
PI3K inhibitor provides durable response in metastatic metaplastic carcinoma of the breast: A hidden gem in the BELLE-4 study. 61
30577988 2019
4
Fibrillin-1, a novel TGF-beta-induced factor, is preferentially expressed in metaplastic carcinoma with spindle sarcomatous metaplasia. 61
31010590 2019
5
Metaplastic carcinoma of the breast: Prognosis and response to systemic treatment in metastatic disease. 61
30925636 2019
6
Metaplastic carcinoma of the breast: A diagnostic challenge on fine needle aspiration cytology. 61
30043535 2019
7
Radiologic Findings of a Rare Subtype of Invasive Breast Cancer with Poor Prognosis: Metaplastic Carcinoma of the Breast. 61
31989886 2019
8
Granulocyte-colony-stimulating factor-producing metaplastic carcinoma of the breast with significant elevation of serum interleukin-17 and vascular endothelial growth factor levels. 61
31149526 2018
9
A Soft Microenvironment Protects from Failure of Midbody Abscission and Multinucleation Downstream of the EMT-Promoting Transcription Factor Snail. 61
29483094 2018
10
Imaging Findings of Metaplastic Carcinoma of the Breast with Pathologic Correlation. 61
30039058 2018
11
Clinicopathological features of metaplastic breast carcinoma. 61
29558027 2018
12
Rare variant of metaplastic carcinoma of the breast: a case report and review of the literature. 61
29463294 2018
13
Metaplastic carcinoma of the breast with mesenchymal differentiation (carcinosarcoma). A unique presentation of an aggressive malignancy and literature review. 61
29504519 2018
14
Metaplastic breast carcinoma: Analysis of 31 cases from a single institute. 61
28669452 2017
15
Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature. 61
28529029 2017
16
Clinicopathological characteristics and prognosis of metaplastic carcinoma of the breast. 61
28781640 2017
17
Primitive squamous cell carcinoma of the breast (SCCB): case report of an uncommon variant of metaplastic carcinoma. 61
29205144 2017
18
Metaplastic carcinoma of the breast: Imaging and pathological features. 61
27895758 2016
19
[Metaplastic carcinoma of the breast: imaging features and clinicopathological characteristics]. 61
27784462 2016
20
Imaging overview of metaplastic carcinomas of the breast: a large study of 71 cases. 61
27245135 2016
21
Metaplastic carcinoma of the breast with widespread telangiectatic form of osteosarcomatous differentiation. 61
26645580 2016
22
[Metaplastic carcinoma of the breast and the impact of the p63 and cytokeratin 5/6: experience of 40 patients]. 61
27424438 2016
23
Pregnancy-like hyperplasia and cystic hypersecretory changes adjacent to metaplastic carcinoma of the breast. 61
26960660 2016
24
[A Case of a Breast Metaplastic Carcinoma with a Giant Cyst]. 61
26805168 2015
25
Four Synchronous Primary Malignancies of the Breast, Lung, Colon and Esophagus. 61
26504043 2015
26
CD99 correlates with low cyclin D1, high topoisomerase 2 status and triple negative molecular phenotype but is prognostically irrelevant in breast carcinoma. 61
26619106 2015
27
Aggressive Metaplastic Carcinoma of the Breast with Osteoclastic Giant Cells. 61
26629304 2015
28
Metaplastic carcinoma of the breast. 61
26030252 2015
29
Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. 61
25677743 2015
30
Metaplastic breast cancer: a comparison between the most common histologies with poor immunohistochemistry factors. 61
25881163 2015
31
A case of matrix-producing metaplastic carcinoma of the breast exhibiting similarities to pleomorphic adenoma on fine-needle aspiration cytology. 61
26823890 2015
32
Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study. 61
25422911 2015
33
Metaplastic breast cancer with chondroid differentiation. 61
26333865 2015
34
[Chondrosarcomatous metaplastic carcinoma of the breast, a rare tumor]. 61
22595382 2014
35
Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype. 61
24903673 2014
36
Metaplastic carcinoma of the breast: an immunohistochemical study. 61
25030022 2014
37
Metaplastic carcinoma of the breast: A case report with review of literature. 61
25494151 2014
38
Phenotypic plasticity in normal breast derived epithelial cells. 61
24915897 2014
39
Metaplastic carcinoma of the breast: Treatment, results and prognostic factors based on international literature. 61
24195912 2014
40
Metaplastic carcinoma of the breast with chondroid differentiation (matrix-producing carcinoma): study of the diagnostic cost-effectiveness of fine-needle aspiration biopsy and needle core biopsy. 61
24246799 2014
41
Metaplastic carcinoma of the breast with rhabdo-myosarcomatous element. 61
25006301 2014
42
Metaplastic carcinoma of the breast: A rare carcinoma with chondroid metaplasia. 61
25931882 2014
43
Primary chondroblastic osteosarcoma of the breast. 61
26033758 2014
44
Metaplastic Breast Carcinoma in the Lungs: A Case Report. 61
29147366 2013
45
The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma. 61
23787124 2013
46
Metaplastic carcinoma of the breast with transformation from adenosquamous carcinoma to osteosarcomatoid and spindle cell morphology. 61
24137400 2013
47
Fibrosarcoma: a challenging diagnosis. 61
31528615 2013
48
[Clinical characteristics and survival analysis of 22 cases of pure epithelial breast metaplastic carcinoma]. 61
24257306 2013
49
Molecular alterations in metaplastic breast carcinoma. 61
23372178 2013
50
Matrix-producing carcinoma of the breast: a case report. 61
23741218 2013
51
Sonographic presentations of metaplastic breast cancers. 61
23158037 2012
52
Metaplastic carcinoma of the right breast and simultaneous giant ovarian teratoma: a case report. 61
22854062 2012
53
Primary chondrosarcoma of male breast: a rare case. 61
24082599 2012
54
Metaplastic carcinoma of the breast with dominant squamous and sebaceous differentiation in the primary tumor and osteochondroid metaplasia in a distant metastasis: report of a case with review of sebaceous differentiation in breast tumors. 61
21865268 2012
55
Low-grade fibromatosis-like spindle cell metaplastic carcinoma of the breast: a case report and literature review. 61
22444721 2012
56
Clinicopathologic features of the mixed epithelial and mesenchymal type metaplastic breast carcinoma with myoepithelial differentiation in a subset of six cases. 61
22361036 2012
57
Triple negative mixed metaplastic breast carcinoma with squamous and spindle cells in an 84-year-old woman: a rare entity with unclear management strategy and poor prognosis. 61
22665553 2012
58
Metaplastic carcinoma of the breast: multimodality imaging and histopathologic assessment. 61
22090465 2012
59
Review of metaplastic carcinoma of the breast: imaging findings and pathologic features. 61
22616038 2012
60
Breast metaplastic carcinoma with unusual small cell component. 61
23507669 2012
61
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era. 61
21792625 2011
62
Metaplastic carcinoma of the breast: clinicopathological features and immunohistochemical analysis. 61
22331717 2011
63
Carcinoma of the breast with choriocarcinomatous features. 61
21877993 2011
64
A case of metaplastic carcinoma of the breast. 61
21803877 2011
65
Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer. 61
21482991 2011
66
Metaplastic carcinoma of the breast with high grade spindle cell component with osteoid formation--a rare case report. 61
21954743 2011
67
Giant sarcomatoid carcinoma of the breast - a rare case report. 61
22368697 2011
68
Twelve cases of metaplastic carcinoma of the breast: experience of the university hospital of Fez Morocco. 61
20454905 2011
69
Metaplastic carcinoma of the breast with neuroectodermal stromal component. 61
21437182 2011
70
Spindle Cell Metaplastic Breast Carcinoma with Leiomyoid Differentiation: A Case Report. 61
21779230 2011
71
Challenges to diagnose metaplastic carcinoma of the breast through cytologic methods: an eight-case series. 61
21244696 2011
72
Metaplastic carcinoma of the breast: cytological diagnosis and diagnostic pitfalls. 61
21791899 2011
73
A case of metaplastic carcinoma of the breast responsive to chemotherapy with Ifosfamide and Etoposide: improved antitumor response by targeting sarcomatous features. 61
21070449 2010
74
Fibromatosislike metaplastic carcinoma of the breast as a diagnostic pitfall for fine needle aspiration cytology: a case report. 61
20968161 2010
75
Keloid type of fibromatosis-like metaplastic carcinoma of the breast with transformation into biphasic tumour in recurrences and lymph node metastases. 61
20716174 2010
76
[Matrix-producing metaplastic carcinoma of the breast]. 61
19896123 2010
77
Metaplastic carcinoma of the breast. 61
20236684 2010
78
SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma. 61
20210803 2010
79
Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications. 61
20153509 2010
80
Metaplastic carcinoma of the breast-a rare neoplasm with transitional cell differentiation: an exceptional feature. 61
20551558 2010
81
Primary nasal-type natural killer/T-cell lymphoma of pterygopalatine fossa. 61
20216452 2010
82
Mixed metaplastic carcinoma of the breast associated with pregnancy: Diagnostic dilemmas in fine-needle aspiration cytology. 61
19459158 2009
83
Metaplastic breast carcinoma with melanocytic differentiation. 61
19712138 2009
84
A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis. 61
19578404 2009
85
Carcinosarcoma of the breast: two case reports and review of the literature. 61
19126225 2009
86
Report of a metaplastic carcinoma of the breast with multi-directional differentiation: an adenoid cystic carcinoma, a spindle cell carcinoma and melanoma. 61
18283489 2008
87
Laminin 5 expression in metaplastic breast carcinomas. 61
18300817 2008
88
Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition. 61
17603561 2007
89
Fine-needle aspiration cytology of metaplastic carcinoma of the breast. 61
16798932 2007
90
Metaplastic carcinoma of the breast (carcinosarcoma variant): a case report. 61
17883089 2007
91
Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. 61
17009109 2007
92
Metaplastic carcinoma of the breast, an intriguing rarity. 61
17250450 2006
93
Metaplastic carcinoma of the breast: a clinicopathological review. 61
16467167 2006
94
Metaplastic carcinoma of the breast with neuroglial differentiation. 61
16253505 2006
95
Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms. 61
16639692 2006
96
[Metaplastic carcinoma of the breast: magnetic resonance and radiophatologic correlation]. 61
17058637 2006
97
Giant cystic metaplastic carcinoma of the breast: a case report with diagnosis by fine needle aspiration. 61
16780030 2006
98
Metaplastic carcinoma of the breast: a retrospective review. 61
16246496 2006
99
p63 is useful in the diagnosis of mammary metaplastic carcinomas. 61
16484002 2006
100
Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. 61
16546865 2006
101
Metaplastic sarcomatoid carcinoma of the breast with absent or minimal overt invasive carcinomatous component: a misnomer. 61
16224212 2005
102
Metaplastic breast cancer: clinical features and outcomes. 61
16468506 2005
103
MRI of metaplastic carcinoma of the breast. 61
15788609 2005
104
[Chondroid matrix-producing metaplastic carcinoma of the breast]. 61
16091186 2005
105
Metaplastic carcinoma of the breast in an HIV-positive patient: a case report. 61
15839630 2005
106
p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components. 61
15376261 2004
107
Invasive ductal carcinoma of the breast with a large central acellular zone associated with matrix-producing carcinoma. 61
15656336 2004
108
[Matrix-producing breast carcinoma with myoepithelial differentiation--description of 11 cases and review of literature aimed at histogenesis and differential diagnosis]. 61
15310000 2004
109
Metaplastic carcinoma of the breast--a rare breast tumour. 61
16295473 2004
110
Magnetic resonance imaging of metaplastic carcinoma of the breast: sonographic and pathologic correlation. 61
15164774 2004
111
Pathologic quiz case: a 49-year-old woman with a lower outer quadrant left breast mass. Matrix-producing metaplastic carcinoma of the breast. 61
14521447 2003
112
[Metaplastic carcinoma of the breast: case report of a sarcomatoid type and literature review]. 61
15623141 2003
113
Metaplastic carcinoma of the breast with rhabdomyosarcomatous element: aspiration cytology with histological, immunohistochemical, and ultrastructural correlations. 61
12619098 2003
114
[Metaplastic spindle-cell (fibromatosis-like) carcinoma of the breast--report of 4 cases]. 61
12629863 2002
115
Metaplastic carcinoma of the breast: clinical, mammographic, and sonographic findings with histopathologic correlation. 61
12034610 2002
116
Sarcomatoid/metaplastic carcinoma of the breast: a clinicopathological study of 12 cases. 61
11903598 2002
117
Sarcoma and Sarcomatous Metaplastic Carcinoma of the Breast. 61
26680823 2001
118
Metastatic metaplastic carcinoma of the breast (MCB): an uncharacteristic pattern of presentation with clinicopathologic correlation. 61
11747217 2001
119
Metaplastic carcinoma of the breast: p53 analysis identified the same point mutation in the three histologic components. 61
11706082 2001
120
[Breast chondrosarcoma: a case report and review]. 61
11373590 2001
121
Limitations of fine-needle aspiration cytology to diagnose metaplastic carcinoma of the breast. 61
11882910 2001
122
Metaplastic carcinoma of the breast: mammographic and sonographic findings. 61
10751739 2000
123
Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer. 61
10928181 2000
124
Metaplastic carcinoma of the breast arising within complex sclerosing lesion: a report of five cases. 61
10692021 2000
125
Metaplastic breast carcinoma metastatic to the lung mimicking a primary chondroid lesion: report of a case with cytohistologic correlation. 61
9845737 1998
126
Metaplastic carcinoma of the breast: report of three cases. 61
9506353 1998
127
Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements. 61
9500219 1998
128
Intraductal papilloma associated with metaplastic carcinoma of the breast. 61
9416498 1997
129
Metaplastic carcinoma of the breast: mammographic appearance with pathologic correlation. 61
9275883 1997
130
Metaplastic carcinoma of the breast with melanocytic differentiation. 61
9195577 1997
131
Chondrosarcomatous cutaneous metastasis. A unique manifestation of sarcomatoid (metaplastic) breast carcinoma. 61
8902102 1996
132
Fine-needle aspiration biopsy of metaplastic carcinoma of the breast: report of a case with abundant myxoid ground substance. 61
8725133 1996
133
[A case report of a metaplastic carcinoma of the breast diagnosed by the preoperative needle biopsy]. 61
7731462 1995
134
Metaplastic carcinoma of the breast in a renal transplant recipient. Initial diagnosis by fine needle aspiration cytology and immunocytochemistry. 61
7992579 1994
135
Metaplastic carcinoma of the breast: a cytopathologic and immunochemical study. 61
8038420 1994
136
[Metaplastic carcinoma of the breast as a second neoplasm. Report of a case]. 61
8337544 1993
137
Metaplastic carcinoma of the breast--diagnosis by aspiration biopsy cytology: report of two cases and literature review. 61
2182315 1990
138
Primary osteogenic sarcoma and osteogenic metaplastic carcinoma of the breast. Immunocytochemical identification in fine needle aspirates. 61
2781963 1989
139
Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. 61
2544506 1989
140
Metaplastic carcinoma of the breast: fine-needle aspiration cytology of seven cases. 61
2721350 1989
141
Metastatic metaplastic carcinoma of the breast: diagnosis by bronchial brush cytology. 61
2612316 1989
142
Cytophotometric measurements of metaplastic carcinoma of the breast: correlation with pathologic features and clinical behavior. 61
3237700 1988
143
Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. 61
2825549 1987

Variations for Breast Metaplastic Carcinoma

Cosmic variations for Breast Metaplastic Carcinoma:

9 (showing 328, show less)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM149270839 ZFHX3 breast,NS,carcinoma,metaplastic carcinoma c.4282G>A p.A1428T 16:72798400-72798400 24
2 COSM87897914 TP53 breast,NS,carcinoma,metaplastic carcinoma c.527G>T p.C176F 17:7675085-7675085 24
3 COSM87897745 TP53 breast,NS,carcinoma,metaplastic carcinoma c.524G>A p.R175H 17:7675088-7675088 24
4 COSM87901171 TP53 breast,NS,carcinoma,metaplastic carcinoma c.395A>G p.K132R 17:7675217-7675217 24
5 COSM87899887 TP53 breast,NS,carcinoma,metaplastic carcinoma c.856G>A p.E286K 17:7673764-7673764 24
6 COSM87898351 TP53 breast,NS,carcinoma,metaplastic carcinoma c.743G>A p.R248Q 17:7674220-7674220 24
7 COSM87916300 TP53 breast,NS,carcinoma,metaplastic carcinoma c.559+1G>T p.? 17:7675052-7675052 24
8 COSM92935208 RBM10 breast,NS,carcinoma,metaplastic carcinoma c.883C>G p.R295G 23:47179127-47179127 24
9 COSM86640825 RB1 breast,NS,carcinoma,metaplastic carcinoma c.607+2T>A p.? 13:48349025-48349025 24
10 COSM86631064 RB1 breast,NS,carcinoma,metaplastic carcinoma c.1421+1G>C p.? 13:48380085-48380085 24
11 COSM96851572 PTEN breast,NS,carcinoma,metaplastic carcinoma c.402G>T p.M134I 10:87933161-87933161 24
12 COSM87132308 PIK3CA breast,NS,carcinoma,metaplastic carcinoma c.1633G>A p.E545K 3:179218303-179218303 24
13 COSM87132245 PIK3CA breast,NS,carcinoma,metaplastic carcinoma c.3140A>G p.H1047R 3:179234297-179234297 24
14 COSM93686153 NF1 breast,NS,carcinoma,metaplastic carcinoma c.634G>C p.V212L 17:31181469-31181469 24
15 COSM93684555 NF1 breast,NS,carcinoma,metaplastic carcinoma c.3082G>T p.D1028Y 17:31230351-31230351 24
16 COSM86881037 IRS1 breast,NS,carcinoma,metaplastic carcinoma c.3564C>A p.F1188L 2:226795175-226795175 24
17 COSM112989160 HRAS breast,NS,carcinoma,metaplastic carcinoma c.38G>T p.G13V 11:534285-534285 24
18 COSM88026384 FLT4 breast,NS,carcinoma,metaplastic carcinoma c.2890G>T p.V964L 5:180618881-180618881 24
19 COSM141964068 FBXW7 breast,NS,carcinoma,metaplastic carcinoma c.1418+2T>G p.? 4:152328206-152328206 24
20 COSM150915971 CTNNB1 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
21 COSM150913524 CTNNB1 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
22 COSM150920852 CTNNB1 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
23 COSM150914069 CTNNB1 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
24 COSM119229461 CDKN2A breast,NS,carcinoma,metaplastic carcinoma c.238C>T p.R80* 9:21971121-21971121 24
25 COSM119255539 CDKN2A breast,NS,carcinoma,metaplastic carcinoma c.104G>T p.G35V 9:21974724-21974724 24
26 COSM88891939 APC breast,NS,carcinoma,metaplastic carcinoma c.3928A>T p.K1310* 5:112839522-112839522 24
27 COSM88878203 APC breast,NS,carcinoma,metaplastic carcinoma c.4616C>G p.S1539* 5:112840210-112840210 24
28 COSM150733597 breast,NS,carcinoma,metaplastic carcinoma c.77C>G p.S26C 3:41224610-41224610 24
29 COSM102023841 breast,NS,carcinoma,metaplastic carcinoma c.1540G>A p.A514T 16:72798400-72798400 24
30 COSM151979892 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
31 COSM93534586 breast,NS,carcinoma,metaplastic carcinoma c.634G>C p.V212L 17:31181469-31181469 24
32 COSM149383649 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
33 COSM149973543 breast,NS,carcinoma,metaplastic carcinoma c.76T>A p.S26T 3:41224609-41224609 24
34 COSM151558491 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
35 COSM93183490 breast,NS,carcinoma,metaplastic carcinoma c.527G>T p.C176F 17:7675085-7675085 24
36 COSM143943797 breast,NS,carcinoma,metaplastic carcinoma c.266G>A p.R89Q 17:7674220-7674220 24
37 COSM120516671 breast,NS,carcinoma,metaplastic carcinoma c.634G>C p.V212L 17:31181469-31181469 24
38 COSM119517378 breast,NS,carcinoma,metaplastic carcinoma c.214G>C p.V72L 17:31181469-31181469 24
39 COSM121154437 breast,NS,carcinoma,metaplastic carcinoma c.-3-3516G>T p.? 9:21974724-21974724 24
40 COSM129356649 breast,NS,carcinoma,metaplastic carcinoma c.194-3516G>T p.? 9:21974724-21974724 24
41 COSM142837093 breast,NS,carcinoma,metaplastic carcinoma c.524G>A p.R175H 17:7675088-7675088 24
42 COSM151593674 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
43 COSM120401214 breast,NS,carcinoma,metaplastic carcinoma c.-3-3516G>T p.? 9:21974724-21974724 24
44 COSM143370869 breast,NS,carcinoma,metaplastic carcinoma c.626G>A p.R209Q 17:7674220-7674220 24
45 COSM150279506 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
46 COSM111758576 breast,NS,carcinoma,metaplastic carcinoma c.743G>A p.R248Q 17:7674220-7674220 24
47 COSM150873918 breast,NS,carcinoma,metaplastic carcinoma c.76T>A p.S26T 3:41224609-41224609 24
48 COSM151980025 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
49 COSM149480245 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
50 COSM149584616 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
51 COSM150960990 breast,NS,carcinoma,metaplastic carcinoma c.77C>G p.S26C 3:41224610-41224610 24
52 COSM106052917 breast,NS,carcinoma,metaplastic carcinoma c.524G>A p.R175H 17:7675088-7675088 24
53 COSM150820564 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
54 COSM105892304 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
55 COSM112253622 breast,NS,carcinoma,metaplastic carcinoma c.743G>A p.R248Q 17:7674220-7674220 24
56 COSM150314348 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
57 COSM142837248 breast,NS,carcinoma,metaplastic carcinoma c.527G>T p.C176F 17:7675085-7675085 24
58 COSM151325856 breast,NS,carcinoma,metaplastic carcinoma c.77C>G p.S26C 3:41224610-41224610 24
59 COSM101967557 breast,NS,carcinoma,metaplastic carcinoma c.38G>T p.G13V 11:534285-534285 24
60 COSM151327498 breast,NS,carcinoma,metaplastic carcinoma c.104C>G p.T35R 3:41224637-41224637 24
61 COSM151307532 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
62 COSM145020627 breast,NS,carcinoma,metaplastic carcinoma c.278A>G p.K93R 17:7675217-7675217 24
63 COSM151493665 breast,NS,carcinoma,metaplastic carcinoma c.104C>G p.T35R 3:41224637-41224637 24
64 COSM145019215 breast,NS,carcinoma,metaplastic carcinoma c.739G>A p.E247K 17:7673764-7673764 24
65 COSM143370595 breast,NS,carcinoma,metaplastic carcinoma c.407G>A p.R136H 17:7675088-7675088 24
66 COSM151343377 breast,NS,carcinoma,metaplastic carcinoma c.77C>G p.S26C 3:41224610-41224610 24
67 COSM142308962 breast,NS,carcinoma,metaplastic carcinoma c.1418+2T>G p.? 4:152328206-152328206 24
68 COSM149390038 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
69 COSM148932633 breast,NS,carcinoma,metaplastic carcinoma c.*220A>G p.? 3:179234297-179234297 24
70 COSM109970323 breast,NS,carcinoma,metaplastic carcinoma c.634G>C p.V212L 17:31181469-31181469 24
71 COSM144668019 breast,NS,carcinoma,metaplastic carcinoma c.442+1G>T p.? 17:7675052-7675052 24
72 COSM111893501 breast,NS,carcinoma,metaplastic carcinoma c.77C>G p.S26C 3:41224610-41224610 24
73 COSM150107132 breast,NS,carcinoma,metaplastic carcinoma c.76T>A p.S26T 3:41224609-41224609 24
74 COSM149485601 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
75 COSM142560281 breast,NS,carcinoma,metaplastic carcinoma c.626G>A p.R209Q 17:7674220-7674220 24
76 COSM122272986 breast,NS,carcinoma,metaplastic carcinoma c.460G>A p.E154K 17:7673764-7673764 24
77 COSM150739145 breast,NS,carcinoma,metaplastic carcinoma c.76T>A p.S26T 3:41224609-41224609 24
78 COSM121875575 breast,NS,carcinoma,metaplastic carcinoma c.128G>A p.R43H 17:7675088-7675088 24
79 COSM111894351 breast,NS,carcinoma,metaplastic carcinoma c.89C>A p.S30Y 3:41224622-41224622 24
80 COSM151345483 breast,NS,carcinoma,metaplastic carcinoma c.104C>G p.T35R 3:41224637-41224637 24
81 COSM151310402 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
82 COSM122733880 breast,NS,carcinoma,metaplastic carcinoma c.128G>A p.R43H 17:7675088-7675088 24
83 COSM112253124 breast,NS,carcinoma,metaplastic carcinoma c.524G>A p.R175H 17:7675088-7675088 24
84 COSM149591208 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
85 COSM142839188 breast,NS,carcinoma,metaplastic carcinoma c.395A>G p.K132R 17:7675217-7675217 24
86 COSM149481652 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
87 COSM146242709 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
88 COSM105619860 breast,NS,carcinoma,metaplastic carcinoma c.524G>A p.R175H 17:7675088-7675088 24
89 COSM151979811 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
90 COSM89373560 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
91 COSM122271559 breast,NS,carcinoma,metaplastic carcinoma c.347G>A p.R116Q 17:7674220-7674220 24
92 COSM111759858 breast,NS,carcinoma,metaplastic carcinoma c.856G>A p.E286K 17:7673764-7673764 24
93 COSM150814125 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
94 COSM150452124 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
95 COSM105899945 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
96 COSM150095331 breast,NS,carcinoma,metaplastic carcinoma c.104C>G p.T35R 3:41224637-41224637 24
97 COSM150868497 breast,NS,carcinoma,metaplastic carcinoma c.89C>A p.S30Y 3:41224622-41224622 24
98 COSM145519507 breast,NS,carcinoma,metaplastic carcinoma c.457C>G p.R153G 23:47179127-47179127 24
99 COSM106068005 breast,NS,carcinoma,metaplastic carcinoma c.559+1G>T p.? 17:7675052-7675052 24
100 COSM89368040 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
101 COSM150816570 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
102 COSM122271291 breast,NS,carcinoma,metaplastic carcinoma c.128G>A p.R43H 17:7675088-7675088 24
103 COSM150967073 breast,NS,carcinoma,metaplastic carcinoma c.76T>A p.S26T 3:41224609-41224609 24
104 COSM143945161 breast,NS,carcinoma,metaplastic carcinoma c.379G>A p.E127K 17:7673764-7673764 24
105 COSM102378140 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
106 COSM142560114 breast,NS,carcinoma,metaplastic carcinoma c.410G>T p.C137F 17:7675085-7675085 24
107 COSM151308416 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
108 COSM109691664 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
109 COSM142562472 breast,NS,carcinoma,metaplastic carcinoma c.278A>G p.K93R 17:7675217-7675217 24
110 COSM149957298 breast,NS,carcinoma,metaplastic carcinoma c.77C>G p.S26C 3:41224610-41224610 24
111 COSM93183630 breast,NS,carcinoma,metaplastic carcinoma c.743G>A p.R248Q 17:7674220-7674220 24
112 COSM106053064 breast,NS,carcinoma,metaplastic carcinoma c.527G>T p.C176F 17:7675085-7675085 24
113 COSM109696453 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
114 COSM151597902 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
115 COSM90891939 breast,NS,carcinoma,metaplastic carcinoma c.457C>G p.R153G 23:47179127-47179127 24
116 COSM149958957 breast,NS,carcinoma,metaplastic carcinoma c.89C>A p.S30Y 3:41224622-41224622 24
117 COSM150141834 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
118 COSM142837352 breast,NS,carcinoma,metaplastic carcinoma c.743G>A p.R248Q 17:7674220-7674220 24
119 COSM151828629 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
120 COSM143372155 breast,NS,carcinoma,metaplastic carcinoma c.739G>A p.E247K 17:7673764-7673764 24
121 COSM142838326 breast,NS,carcinoma,metaplastic carcinoma c.856G>A p.E286K 17:7673764-7673764 24
122 COSM122749108 breast,NS,carcinoma,metaplastic carcinoma c.163+1G>T p.? 17:7675052-7675052 24
123 COSM143158111 breast,NS,carcinoma,metaplastic carcinoma c.379G>A p.E127K 17:7673764-7673764 24
124 COSM150867925 breast,NS,carcinoma,metaplastic carcinoma c.77C>G p.S26C 3:41224610-41224610 24
125 COSM151331219 breast,NS,carcinoma,metaplastic carcinoma c.76T>A p.S26T 3:41224609-41224609 24
126 COSM149296300 breast,NS,carcinoma,metaplastic carcinoma c.104C>G p.T35R 3:41224637-41224637 24
127 COSM146249399 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
128 COSM144322811 breast,NS,carcinoma,metaplastic carcinoma c.442+1G>T p.? 17:7675052-7675052 24
129 COSM111035901 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
130 COSM145032344 breast,NS,carcinoma,metaplastic carcinoma c.442+1G>T p.? 17:7675052-7675052 24
131 COSM146867405 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
132 COSM121875799 breast,NS,carcinoma,metaplastic carcinoma c.131G>T p.C44F 17:7675085-7675085 24
133 COSM139315988 breast,NS,carcinoma,metaplastic carcinoma c.281C>T p.P94L 9:21971121-21971121 24
134 COSM144014790 breast,NS,carcinoma,metaplastic carcinoma c.823G>A p.E275K 17:7673764-7673764 24
135 COSM151564592 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
136 COSM84517981 breast,NS,carcinoma,metaplastic carcinoma c.1418+2T>G p.? 4:152328206-152328206 24
137 COSM93185054 breast,NS,carcinoma,metaplastic carcinoma c.856G>A p.E286K 17:7673764-7673764 24
138 COSM143373513 breast,NS,carcinoma,metaplastic carcinoma c.278A>G p.K93R 17:7675217-7675217 24
139 COSM93186307 breast,NS,carcinoma,metaplastic carcinoma c.395A>G p.K132R 17:7675217-7675217 24
140 COSM149292114 breast,NS,carcinoma,metaplastic carcinoma c.89C>A p.S30Y 3:41224622-41224622 24
141 COSM129326012 breast,NS,carcinoma,metaplastic carcinoma c.281C>T p.P94L 9:21971121-21971121 24
142 COSM110179052 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
143 COSM111041206 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
144 COSM149290244 breast,NS,carcinoma,metaplastic carcinoma c.77C>G p.S26C 3:41224610-41224610 24
145 COSM144650780 breast,NS,carcinoma,metaplastic carcinoma c.407G>A p.R136H 17:7675088-7675088 24
146 COSM150526069 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
147 COSM144309944 breast,NS,carcinoma,metaplastic carcinoma c.407G>A p.R136H 17:7675088-7675088 24
148 COSM150660062 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
149 COSM86260992 breast,NS,carcinoma,metaplastic carcinoma c.238C>T p.R80* 9:21971121-21971121 24
150 COSM150457121 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
151 COSM111891051 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
152 COSM150088060 breast,NS,carcinoma,metaplastic carcinoma c.77C>G p.S26C 3:41224610-41224610 24
153 COSM146869071 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
154 COSM138033912 breast,NS,carcinoma,metaplastic carcinoma c.85C>T p.R29* 9:21971121-21971121 24
155 COSM148932727 breast,NS,carcinoma,metaplastic carcinoma c.1633G>A p.E545K 3:179218303-179218303 24
156 COSM105621918 breast,NS,carcinoma,metaplastic carcinoma c.782+417G>A p.? 17:7673764-7673764 24
157 COSM143156843 breast,NS,carcinoma,metaplastic carcinoma c.266G>A p.R89Q 17:7674220-7674220 24
158 COSM111886789 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
159 COSM102451685 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
160 COSM150274793 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
161 COSM138542962 breast,NS,carcinoma,metaplastic carcinoma c.104G>T p.G35V 9:21974724-21974724 24
162 COSM106054649 breast,NS,carcinoma,metaplastic carcinoma c.856G>A p.E286K 17:7673764-7673764 24
163 COSM150146679 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
164 COSM122735403 breast,NS,carcinoma,metaplastic carcinoma c.460G>A p.E154K 17:7673764-7673764 24
165 COSM150535415 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
166 COSM144013113 breast,NS,carcinoma,metaplastic carcinoma c.491G>A p.R164H 17:7675088-7675088 24
167 COSM151748615 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
168 COSM145017326 breast,NS,carcinoma,metaplastic carcinoma c.407G>A p.R136H 17:7675088-7675088 24
169 COSM149963294 breast,NS,carcinoma,metaplastic carcinoma c.104C>G p.T35R 3:41224637-41224637 24
170 COSM144652672 breast,NS,carcinoma,metaplastic carcinoma c.739G>A p.E247K 17:7673764-7673764 24
171 COSM145017511 breast,NS,carcinoma,metaplastic carcinoma c.410G>T p.C137F 17:7675085-7675085 24
172 COSM150735829 breast,NS,carcinoma,metaplastic carcinoma c.104C>G p.T35R 3:41224637-41224637 24
173 COSM109705732 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
174 COSM89382422 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
175 COSM151560687 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
176 COSM144099066 breast,NS,carcinoma,metaplastic carcinoma c.82+1G>T p.? 17:7675052-7675052 24
177 COSM109692783 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
178 COSM150659413 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
179 COSM144087046 breast,NS,carcinoma,metaplastic carcinoma c.50G>T p.C17F 17:7675085-7675085 24
180 COSM146873458 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
181 COSM121893172 breast,NS,carcinoma,metaplastic carcinoma c.163+1G>T p.? 17:7675052-7675052 24
182 COSM144311386 breast,NS,carcinoma,metaplastic carcinoma c.739G>A p.E247K 17:7673764-7673764 24
183 COSM142559914 breast,NS,carcinoma,metaplastic carcinoma c.407G>A p.R136H 17:7675088-7675088 24
184 COSM149492744 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
185 COSM143156608 breast,NS,carcinoma,metaplastic carcinoma c.47G>A p.R16H 17:7675088-7675088 24
186 COSM144013367 breast,NS,carcinoma,metaplastic carcinoma c.710G>A p.R237Q 17:7674220-7674220 24
187 COSM150453483 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
188 COSM150309649 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
189 COSM150286555 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
190 COSM151491337 breast,NS,carcinoma,metaplastic carcinoma c.77C>G p.S26C 3:41224610-41224610 24
191 COSM142561493 breast,NS,carcinoma,metaplastic carcinoma c.739G>A p.E247K 17:7673764-7673764 24
192 COSM122274028 breast,NS,carcinoma,metaplastic carcinoma c.-2A>G p.? 17:7675217-7675217 24
193 COSM102450338 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
194 COSM150090124 breast,NS,carcinoma,metaplastic carcinoma c.89C>A p.S30Y 3:41224622-41224622 24
195 COSM151344986 breast,NS,carcinoma,metaplastic carcinoma c.77C>G p.S26C 3:41224610-41224610 24
196 COSM151812022 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
197 COSM149385782 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
198 COSM111897242 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
199 COSM144027143 breast,NS,carcinoma,metaplastic carcinoma c.526+1G>T p.? 17:7675052-7675052 24
200 COSM121879352 breast,NS,carcinoma,metaplastic carcinoma c.-2A>G p.? 17:7675217-7675217 24
201 COSM144650965 breast,NS,carcinoma,metaplastic carcinoma c.410G>T p.C137F 17:7675085-7675085 24
202 COSM105620097 breast,NS,carcinoma,metaplastic carcinoma c.527G>T p.C176F 17:7675085-7675085 24
203 COSM150311115 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
204 COSM122734074 breast,NS,carcinoma,metaplastic carcinoma c.131G>T p.C44F 17:7675085-7675085 24
205 COSM143957376 breast,NS,carcinoma,metaplastic carcinoma c.82+1G>T p.? 17:7675052-7675052 24
206 COSM122392550 breast,NS,carcinoma,metaplastic carcinoma c.4616C>G p.S1539* 5:112840210-112840210 24
207 COSM102466371 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
208 COSM151344038 breast,NS,carcinoma,metaplastic carcinoma c.89C>A p.S30Y 3:41224622-41224622 24
209 COSM112254871 breast,NS,carcinoma,metaplastic carcinoma c.856G>A p.E286K 17:7673764-7673764 24
210 COSM101049303 breast,NS,carcinoma,metaplastic carcinoma c.2890G>T p.V964L 5:180618881-180618881 24
211 COSM150662141 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
212 COSM144087977 breast,NS,carcinoma,metaplastic carcinoma c.379G>A p.E127K 17:7673764-7673764 24
213 COSM151816770 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
214 COSM122734176 breast,NS,carcinoma,metaplastic carcinoma c.347G>A p.R116Q 17:7674220-7674220 24
215 COSM102384503 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
216 COSM111887940 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
217 COSM111761369 breast,NS,carcinoma,metaplastic carcinoma c.395A>G p.K132R 17:7675217-7675217 24
218 COSM150814680 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
219 COSM151827541 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
220 COSM139340693 breast,NS,carcinoma,metaplastic carcinoma c.194-3516G>T p.? 9:21974724-21974724 24
221 COSM151591993 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
222 COSM105623043 breast,NS,carcinoma,metaplastic carcinoma c.395A>G p.K132R 17:7675217-7675217 24
223 COSM143156755 breast,NS,carcinoma,metaplastic carcinoma c.50G>T p.C17F 17:7675085-7675085 24
224 COSM150526956 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
225 COSM151348165 breast,NS,carcinoma,metaplastic carcinoma c.76T>A p.S26T 3:41224609-41224609 24
226 COSM150322493 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
227 COSM105636669 breast,NS,carcinoma,metaplastic carcinoma c.559+1G>T p.? 17:7675052-7675052 24
228 COSM150275820 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
229 COSM101951953 breast,NS,carcinoma,metaplastic carcinoma c.38G>T p.G13V 11:534285-534285 24
230 COSM150870192 breast,NS,carcinoma,metaplastic carcinoma c.104C>G p.T35R 3:41224637-41224637 24
231 COSM150963688 breast,NS,carcinoma,metaplastic carcinoma c.104C>G p.T35R 3:41224637-41224637 24
232 COSM144310203 breast,NS,carcinoma,metaplastic carcinoma c.626G>A p.R209Q 17:7674220-7674220 24
233 COSM151591310 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
234 COSM100935864 breast,NS,carcinoma,metaplastic carcinoma c.688C>G p.R230G 23:47179127-47179127 24
235 COSM149586487 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
236 COSM102456283 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
237 COSM93199158 breast,NS,carcinoma,metaplastic carcinoma c.559+1G>T p.? 17:7675052-7675052 24
238 COSM120376601 breast,NS,carcinoma,metaplastic carcinoma c.85C>T p.R29* 9:21971121-21971121 24
239 COSM143159037 breast,NS,carcinoma,metaplastic carcinoma c.-83A>G p.? 17:7675217-7675217 24
240 COSM143864595 breast,NS,carcinoma,metaplastic carcinoma c.*1833G>T p.? 5:180618881-180618881 24
241 COSM151349108 breast,NS,carcinoma,metaplastic carcinoma c.76T>A p.S26T 3:41224609-41224609 24
242 COSM121878041 breast,NS,carcinoma,metaplastic carcinoma c.460G>A p.E154K 17:7673764-7673764 24
243 COSM88396861 breast,NS,carcinoma,metaplastic carcinoma c.1064+2T>G p.? 4:152328206-152328206 24
244 COSM151755838 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
245 COSM121875983 breast,NS,carcinoma,metaplastic carcinoma c.347G>A p.R116Q 17:7674220-7674220 24
246 COSM122407236 breast,NS,carcinoma,metaplastic carcinoma c.3928A>T p.K1310* 5:112839522-112839522 24
247 COSM111758247 breast,NS,carcinoma,metaplastic carcinoma c.524G>A p.R175H 17:7675088-7675088 24
248 COSM111049618 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
249 COSM151315204 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
250 COSM112269265 breast,NS,carcinoma,metaplastic carcinoma c.559+1G>T p.? 17:7675052-7675052 24
251 COSM87276804 breast,NS,carcinoma,metaplastic carcinoma c.1178+2T>G p.? 4:152328206-152328206 24
252 COSM144088998 breast,NS,carcinoma,metaplastic carcinoma c.-83A>G p.? 17:7675217-7675217 24
253 COSM122271418 breast,NS,carcinoma,metaplastic carcinoma c.131G>T p.C44F 17:7675085-7675085 24
254 COSM144651115 breast,NS,carcinoma,metaplastic carcinoma c.626G>A p.R209Q 17:7674220-7674220 24
255 COSM105889245 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
256 COSM150529612 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
257 COSM106055648 breast,NS,carcinoma,metaplastic carcinoma c.395A>G p.K132R 17:7675217-7675217 24
258 COSM86290788 breast,NS,carcinoma,metaplastic carcinoma c.104G>T p.G35V 9:21974724-21974724 24
259 COSM150465447 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
260 COSM98403450 breast,NS,carcinoma,metaplastic carcinoma c.1178+2T>G p.? 4:152328206-152328206 24
261 COSM151559042 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
262 COSM111037309 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
263 COSM143370731 breast,NS,carcinoma,metaplastic carcinoma c.410G>T p.C137F 17:7675085-7675085 24
264 COSM143169292 breast,NS,carcinoma,metaplastic carcinoma c.82+1G>T p.? 17:7675052-7675052 24
265 COSM105721732 breast,NS,carcinoma,metaplastic carcinoma c.38G>T p.G13V 11:534285-534285 24
266 COSM151826971 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
267 COSM151980302 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
268 COSM151346645 breast,NS,carcinoma,metaplastic carcinoma c.104C>G p.T35R 3:41224637-41224637 24
269 COSM151813887 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
270 COSM93183307 breast,NS,carcinoma,metaplastic carcinoma c.524G>A p.R175H 17:7675088-7675088 24
271 COSM102393964 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
272 COSM111896688 breast,NS,carcinoma,metaplastic carcinoma c.104C>G p.T35R 3:41224637-41224637 24
273 COSM150143021 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
274 COSM105887873 breast,NS,carcinoma,metaplastic carcinoma c.98C>G p.S33C 3:41224610-41224610 24
275 COSM106053189 breast,NS,carcinoma,metaplastic carcinoma c.743G>A p.R248Q 17:7674220-7674220 24
276 COSM151749325 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
277 COSM102379701 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
278 COSM146244653 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
279 COSM151326439 breast,NS,carcinoma,metaplastic carcinoma c.89C>A p.S30Y 3:41224622-41224622 24
280 COSM151751232 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
281 COSM146260474 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
282 COSM93533564 breast,NS,carcinoma,metaplastic carcinoma c.3082G>T p.D1028Y 17:31230351-31230351 24
283 COSM143943565 breast,NS,carcinoma,metaplastic carcinoma c.47G>A p.R16H 17:7675088-7675088 24
284 COSM151345393 breast,NS,carcinoma,metaplastic carcinoma c.89C>A p.S30Y 3:41224622-41224622 24
285 COSM144013236 breast,NS,carcinoma,metaplastic carcinoma c.494G>T p.C165F 17:7675085-7675085 24
286 COSM149306698 breast,NS,carcinoma,metaplastic carcinoma c.76T>A p.S26T 3:41224609-41224609 24
287 COSM151812540 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
288 COSM150666356 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
289 COSM150154835 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
290 COSM89369321 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
291 COSM143946472 breast,NS,carcinoma,metaplastic carcinoma c.-83A>G p.? 17:7675217-7675217 24
292 COSM142575130 breast,NS,carcinoma,metaplastic carcinoma c.442+1G>T p.? 17:7675052-7675052 24
293 COSM145017657 breast,NS,carcinoma,metaplastic carcinoma c.626G>A p.R209Q 17:7674220-7674220 24
294 COSM142848797 breast,NS,carcinoma,metaplastic carcinoma c.559+1G>T p.? 17:7675052-7675052 24
295 COSM150961703 breast,NS,carcinoma,metaplastic carcinoma c.89C>A p.S30Y 3:41224622-41224622 24
296 COSM111758423 breast,NS,carcinoma,metaplastic carcinoma c.527G>T p.C176F 17:7675085-7675085 24
297 COSM116002788 breast,NS,carcinoma,metaplastic carcinoma c.85C>T p.R29* 9:21971121-21971121 24
298 COSM110183892 breast,NS,carcinoma,metaplastic carcinoma c.125C>G p.T42R 3:41224637-41224637 24
299 COSM144087106 breast,NS,carcinoma,metaplastic carcinoma c.266G>A p.R89Q 17:7674220-7674220 24
300 COSM143943683 breast,NS,carcinoma,metaplastic carcinoma c.50G>T p.C17F 17:7675085-7675085 24
301 COSM149601733 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
302 COSM91331469 breast,NS,carcinoma,metaplastic carcinoma c.38G>T p.G13V 11:534285-534285 24
303 COSM149398300 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
304 COSM119657740 breast,NS,carcinoma,metaplastic carcinoma c.2890G>T p.V964L 5:180618881-180618881 24
305 COSM144654181 breast,NS,carcinoma,metaplastic carcinoma c.278A>G p.K93R 17:7675217-7675217 24
306 COSM144015802 breast,NS,carcinoma,metaplastic carcinoma c.362A>G p.K121R 17:7675217-7675217 24
307 COSM121125164 breast,NS,carcinoma,metaplastic carcinoma c.85C>T p.R29* 9:21971121-21971121 24
308 COSM143387574 breast,NS,carcinoma,metaplastic carcinoma c.442+1G>T p.? 17:7675052-7675052 24
309 COSM151498067 breast,NS,carcinoma,metaplastic carcinoma c.76T>A p.S26T 3:41224609-41224609 24
310 COSM144312403 breast,NS,carcinoma,metaplastic carcinoma c.278A>G p.K93R 17:7675217-7675217 24
311 COSM146883896 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
312 COSM144086975 breast,NS,carcinoma,metaplastic carcinoma c.47G>A p.R16H 17:7675088-7675088 24
313 COSM112255786 breast,NS,carcinoma,metaplastic carcinoma c.395A>G p.K132R 17:7675217-7675217 24
314 COSM122286594 breast,NS,carcinoma,metaplastic carcinoma c.163+1G>T p.? 17:7675052-7675052 24
315 COSM110180500 breast,NS,carcinoma,metaplastic carcinoma c.110C>A p.S37Y 3:41224622-41224622 24
316 COSM138521235 breast,NS,carcinoma,metaplastic carcinoma c.238C>T p.R80* 9:21971121-21971121 24
317 COSM144310072 breast,NS,carcinoma,metaplastic carcinoma c.410G>T p.C137F 17:7675085-7675085 24
318 COSM111903756 breast,NS,carcinoma,metaplastic carcinoma c.76T>A p.S26T 3:41224609-41224609 24
319 COSM105620276 breast,NS,carcinoma,metaplastic carcinoma c.743G>A p.R248Q 17:7674220-7674220 24
320 COSM150734196 breast,NS,carcinoma,metaplastic carcinoma c.89C>A p.S30Y 3:41224622-41224622 24
321 COSM122736483 breast,NS,carcinoma,metaplastic carcinoma c.-2A>G p.? 17:7675217-7675217 24
322 COSM112253249 breast,NS,carcinoma,metaplastic carcinoma c.527G>T p.C176F 17:7675085-7675085 24
323 COSM122107657 breast,NS,carcinoma,metaplastic carcinoma c.85C>T p.R29* 9:21971121-21971121 24
324 COSM110192757 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
325 COSM151831213 breast,NS,carcinoma,metaplastic carcinoma c.97T>A p.S33T 3:41224609-41224609 24
326 COSM151492062 breast,NS,carcinoma,metaplastic carcinoma c.89C>A p.S30Y 3:41224622-41224622 24
327 COSM87274904 breast,NS,carcinoma,metaplastic carcinoma c.4282G>A p.A1428T 16:72798400-72798400 24
328 COSM111774532 breast,NS,carcinoma,metaplastic carcinoma c.559+1G>T p.? 17:7675052-7675052 24

Expression for Breast Metaplastic Carcinoma

Search GEO for disease gene expression data for Breast Metaplastic Carcinoma.

Pathways for Breast Metaplastic Carcinoma

Pathways related to Breast Metaplastic Carcinoma according to GeneCards Suite gene sharing:

(showing 8, show less)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.22 PGR ESR1 ERBB2 EGFR
2
Show member pathways
12.05 PGR KRT14 ESR1 EGFR
3
Show member pathways
11.93 ESR1 ERBB2 EGFR
4 11.86 ESR1 ERBB2 EGFR
5
Show member pathways
11.1 ESR1 ERBB2 EGFR
6
Show member pathways
10.96 PGR ESR1 ERBB2 EGFR
7 10.9 ERBB2 EGFR
8 10.8 ERBB2 EGFR

GO Terms for Breast Metaplastic Carcinoma

Biological processes related to Breast Metaplastic Carcinoma according to GeneCards Suite gene sharing:

(showing 10, show less)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of protein kinase B signaling GO:0051897 9.58 ESR1 ERBB2 EGFR
2 transcription initiation from RNA polymerase II promoter GO:0006367 9.54 PGR MAML2 ESR1
3 protein autophosphorylation GO:0046777 9.5 ERBB2 EGFR CLK3
4 regulation of cell motility GO:2000145 9.48 ERBB2 EGFR
5 ERBB2 signaling pathway GO:0038128 9.46 ERBB2 EGFR
6 regulation of ERK1 and ERK2 cascade GO:0070372 9.43 ERBB2 EGFR
7 peptidyl-tyrosine phosphorylation GO:0018108 9.43 ERBB2 EGFR CLK3
8 epidermis development GO:0008544 9.33 KRT5 KRT14 EGFR
9 hemidesmosome assembly GO:0031581 8.96 KRT5 KRT14
10 negative regulation of ERBB signaling pathway GO:1901185 8.62 ERBB2 EGFR

Molecular functions related to Breast Metaplastic Carcinoma according to GeneCards Suite gene sharing:

(showing 3, show less)
# Name GO ID Score Top Affiliating Genes
1 protein tyrosine kinase activity GO:0004713 9.33 ERBB2 EGFR CLK3
2 ATPase binding GO:0051117 9.13 PGR ESR1 EGFR
3 nitric-oxide synthase regulator activity GO:0030235 8.62 ESR1 EGFR

Sources for Breast Metaplastic Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....